CSI Market
Sign In | Register

Arch Therapeutics Inc (ARTH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ARTH Annual Cash Flow →
The table below presents a historical view of Arch Therapeutics Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2024)
9 Months 		(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Operating Activities
Income-9.81
Depreciation & amortization0.00
Amortization of Other Assets0.00
Accretion Expense1.85
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.04
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation4.00
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.00
Noncash Interest Expense On Convertible Notes Payable-
Noncash Interest Expense On Notes Payable To Related Party-
Noncash Interest Expense On Notes Payable-
Gain On Exercise Of Warrants-
Issuance Of Restricted Stock For Services Operating Activities-
Increase Decrease In Accrued Expenses And Other Liabilities-0.06
Income taxes0.00
Unrealized Gain (Loss) on Derivatives0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.61
Increase (Decrease) in Interest Payable, Net0.56
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.32
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-2.47
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Debt Conversion Converted Instrument Amount0.61
Fair Value Of Warrants Issued-
Stock Issued-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.61
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net-0.24
Other borrowing transactions0.00
Long-term debt - borrowings2.53
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Common Stock Issued In Merger-
Proceeds From Issuance Of Common Stock And Warrants-
Proceeds From Issuance Of Notes Payable To Related Party-
Proceeds Form Issued Common Stock And Warrants-
Proceeds From Subscribed But Unissued Common Stock And Warrants-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Proceeds From Issuance Of Common Stock And Warrants Net Of Financing Costs-
Proceeds From Advances From Investors-
Proceeds From Convertible Notes Warrants And Common Stock Net Of Financing Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.28
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-2.47
Total Cash Flow-0.19
4 historic quarters locked

Sign in to unlock the full Arch Therapeutics Inc cash flow history.

Sign In Create Free Account

About Arch Therapeutics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240630)
  • Filed with the SEC: August 19, 2024
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-24-033091

Figures are derived from filed reports and may be restated. Historical data is subject to revision.